Is Viatris Stock Underperforming the Dow?

Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a global pharmaceutical and healthcare corporation. With a market cap of $13.6 billion, Viatris operates through Developed Markets, Greater China, JANZ (Japan, Australia, and New Zealand), and Emerging Markets segments.

Companies worth $10 billion or more are generally described as "large-cap stocks," Viatris fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the specialty & generic drug manufacturing industry. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).